Eli Lilly pre-announced a sizable Q4 2024 revenue miss headed into the big J.P. Morgan healthcare investor conference, but the biopharma reported massive growth. A lot of the quarterly ...

Now, the Cubs can turn their focus to pitching. They need a little bit of help in their bullpen, even after acquiring Eli Morgan from the Cleveland Guardians. They could look to spend some money ...

Josh Naylor, Nick Sandlin and Eli Morgan were traded. Triston McKenzie, Ben Lively and Sam Hentges signed one-year deals in November, while James Karinchak was released. If you purchase a product ...

The Cubs agreed to terms on salaries to avoid arbitration with left-hander Justin Steele ($6.55 million) and relievers Nate Pearson ($1.35 million) and Eli Morgan ($950,000). Justin Steele ($6.55 ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,146.00. The company’s shares closed ...

Eli Lilly and Company (NYSE: LLY) will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A. Ricks, Lilly chair and CEO, will participate in a fireside chat on ...

Eli Lilly and Co., which cemented its place in ... life science firms presenting at J.P. Morgan As part of the deal, Scorpion is going to undergo a shakeup. The Boston biotech is going to spin ...

SAN FRANCISCO — Eli Lilly CEO Dave Ricks on Tuesday said he believed the company could find “significant common cause” with the incoming Trump administration, including on issues around ...